Nuclear Regulatory Commission
AGENCY:
U.S. Nuclear Regulatory Commission.
ACTION:
Notice of meeting.
SUMMARY:
The U.S. Nuclear Regulatory Commission (NRC) will convene a virtual meeting of the Advisory Committee on the Medical Uses of Isotopes (ACMUI) on October 26-27, 2026. Agenda items to be discussed during the public session include: a presentation on the outcome of the pilot on exploring using AI to search data in the Nuclear Materials Event Database (NMED), recommendations from ACMUI's subcommittee on radiopharmaceutical production and distribution safety, a presentation on radiological health at the U.S. Food and Drug Administration (FDA), and a presentation on recent medical events. The agenda is subject to change. The current agenda and any updates will be available on the ACMUI's Meetings and Related Documents web page at ACMUI Meetings and Related Documents: 2026 | Nuclear Regulatory Commission or by emailing Ms. Sarah Hoenig at the contact information below. Purpose: Discuss issues related to 10 CFR part 35 Medical Use of Byproduct Material.
10 CFR part 35DATES:
Date and Time for Open Session: October 26, 2026, from 10:00 a.m. to 2:45 p.m. EDT.
Date and Time for Closed Session: October 27, 2026, from 11:00 a.m. to 12:30 p.m. EDT. This session will be closed to conduct the ACMUI's required annual training.
ADDRESSES:
| Date | Webinar information (Microsoft Teams) |
|---|---|
| October 26, 2026 | Link: teams.microsoft.com/meet/213166283153366?p=5pGC3QyZeNAhXyq69K. |
| Meeting ID: 213 166 283 153 366. | |
| Passcode: 85E2QM7g. Call in number (audio only): +1 301-576-2978, United States, Silver Spring. | |
| Phone conference ID: 739 970 19#. |
teams.microsoft.com/meet/213166283153366?p=5pGC3QyZeNAhXyq69KPublic Participation: Any member of the public who wishes to participate in the meeting via Microsoft Teams or via phone should contact Ms. Sarah Hoenig using the information below.
FOR FURTHER INFORMATION CONTACT:
Ms. Sarah Hoenig, email: sarah.hoenig@nrc.gov phone: 301-415-3284.
SUPPLEMENTARY INFORMATION:
Conduct of the Meeting
The ACMUI Chair, Hossein Jadvar, MD, Ph.D., will preside over the meeting. Dr. Jadvar will conduct the meeting in a manner that will facilitate the orderly conduct of business. The following procedures apply to public participation in the meeting:
1. Persons who wish to provide a written statement should submit an electronic copy to Ms. Sarah Hoenig using the contact information listed above. All submittals must be received by the close of business on October 19, 2026, and must only pertain to the topics on the agenda.
2. Questions and comments from members of the public will be permitted during the meeting, at the discretion of the ACMUI Chair.
3. The draft transcript and meeting summary will be available on ACMUI's website ACMUI Meetings and Related Documents: 2026 | Nuclear Regulatory Commission on or about November 27, 2026.
4. Persons who require special services, such as those for the hearing impaired, should notify Ms. Sarah Hoenig of their planned participation.
This meeting will be held in accordance with the Atomic Energy Act of 1954, as amended (primarily 42 U.S.C. 2201(a)); the Federal Advisory Committee Act (5 U.S.C. 1001 et seq.)); and the Commission's regulations in Title 10 of the Code of Federal Regulations, Part 7.
42 U.S.C. 2201(a)Dated at Rockville, Maryland this 7th day of October 2026.
For the U.S. Nuclear Regulatory Commission.
Russell E. Chazell,
Federal Advisory Committee Management Officer.
[FR Doc. 2026-20733 Filed 10-8-26; 8:45 am]
BILLING CODE 7590-01-P